Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions
Journal article
Thézénas M-L. et al, (2020), Scientific Reports, 10
Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10
Journal article
Zhao Y. et al, (2020), Nature Communications, 11
TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts
Journal article
Fielden J. et al, (2020), Nature Communications, 11
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Journal article
Adams ER. et al, (2020), Wellcome Open Research, 5, 139 - 139
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
Journal article
DONG T., (2020), BioRxiv
SAMHD1-mediated dNTP degradation is required for efficient DNA repair during antibody class switch recombination.
Journal article
Husain A. et al, (2020), The EMBO journal
Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease.
Journal article
Zhao Y. et al, (2020), JCI insight
An evidence-based framework for priority clinical research questions for COVID-19.
Journal article
Harris C. et al, (2020), Journal of global health, 10
A novel scoring system for prediction of disease severity in COVID-19
Journal article
DONG TAO., (2020), Frontiers in Cellular and Infection Microbiology, section Virus and Host
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.
Journal article
Dagens A. et al, (2020), BMJ (Clinical research ed.), 369
Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient.
Journal article
Abd Hamid M. et al, (2020), Cellular & molecular immunology
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Journal article
Wang Y. et al, (2020), Trials, 21
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
Journal article
Docherty AB. et al, (2020), BMJ (Clinical research ed.), 369
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Journal article
Cheung VTF. et al, (2020), British Journal of Cancer
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.
Journal article
Rojek A. et al, (2020)
Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.
Journal article
Corridoni D. et al, (2020), Inflammatory bowel diseases
Lassa fever in pregnancy: a systematic review and meta-analysis
Journal article
Kayem ND. et al, (2020), Transactions of The Royal Society of Tropical Medicine and Hygiene, 114, 385 - 396
Longitudinal profiling of cytokines and chemokines in COVID-19 reveals inhibitory mediators IL-1Ra and IL-10 are associated with disease severity while elevated RANTES is an early predictor of mild disease
Journal article
DONG TAO. et al, (2020), Preprint with Lancet
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Journal article
Cao B. et al, (2020), The New England journal of medicine, 382, 1787 - 1799
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Journal article
Wang Y. et al, (2020), Lancet (London, England), 395, 1569 - 1578